Immunocore Holdings (IMCR) Net Income towards Common Stockholders (QoQ) (2023 - 2026)
Immunocore Holdings (IMCR) Net Income towards Common Stockholders (QoQ) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
767,934.24 Bn |
767,934.20 Bn |
- |
| 2 |
Belite Bio |
55,234.00 Bn |
55,234.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,823.14 Bn |
17,823.14 Bn |
- |
| 4 |
Legend Biotech |
3,624.50 Bn |
3,624.21 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,745.73 Bn |
1,745.73 Bn |
- |
| 6 |
Evaxion A |
1,540.85 Bn |
1,540.84 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.57 Bn |
105.33 Bn |
2.59 Bn |
| 9 |
Abivax |
93.46 Bn |
93.46 Bn |
- |
| 10 |
Immunocore Holdings |
1.46 Bn |
616.35 Mn |
106.24 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
143.08% |
| Dec 31, 2025 |
-16,910.17% |
| Sep 30, 2025 |
98.28% |
| Jun 30, 2025 |
-306.54% |
| Mar 31, 2025 |
120.97% |
| Dec 31, 2024 |
-373.45% |
| Sep 30, 2024 |
174.75% |
| Jun 30, 2024 |
52.41% |
| Mar 31, 2024 |
-23.85% |
| Dec 31, 2023 |
-2,277.70% |
| Sep 30, 2023 |
105.33% |
| Jun 30, 2023 |
12.52% |
